Metabolic Alterations in the Amygdala in Borderline Personality Disorder: A Proton Magnetic Resonance Spectroscopy Study

Biological Psychiatry

Volumn 67, Issue 5, 2010, Pages 399-405

  Hoerst, Mareen ^a   Weber Fahr, Wolfgang ^a   Tunc Skarka, Nuran ^a   Ruf, Matthias ^a   Bohus, Martin ^a   Schmahl, Christian ^a   Ende, Gabriele ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

1H MR spectroscopy; Amygdala; borderline personality disorder; posttraumatic stress disorder; total creatine; total N acetylaspartate

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; AFFECT; AMYGDALOID NUCLEUS; ARTICLE; BORDERLINE STATE; BRAIN METABOLISM; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; EMOTIONALITY; FEMALE; HUMAN; LIMBIC SYSTEM; NEUROCHEMISTRY; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMETRY;

ADULT; AMYGDALA; ASPARTIC ACID; BORDERLINE PERSONALITY DISORDER; CREATINE; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 75849119407     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.09.030     Document Type: Article

References (54)

1. Lieb K., Zanarini M.C., Schmahl C., Linehan M.M., and Bohus M. Borderline personality disorder. Lancet 364 (2004) 453-461
2. Coid J., Yang M., Tyrer P., Roberts A., and Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry 188 (2006) 423-431
3. Zanarini M.C., Frankenburg F.R., Dubo E.D., Sickel A.E., Trikha A., Levin A., et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry 155 (1998) 1733-1739
4. Schmahl C., and Bremner J.D. Neuroimaging in borderline personality disorder. J Psychiatr Res 40 (2006) 419-427
5. Driessen M., Herrmann J., Stahl K., Zwaan M., Meier S., Hill A., et al. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch Gen Psychiatry 57 (2000) 1115-1122
6. Rusch N., van Elst L.T., Ludaescher P., Wilke M., Huppertz H.J., Thiel T., et al. A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage 20 (2003) 385-392
7. Schmahl C.G., Vermetten E., Elzinga B.M., and Douglas Bremner J. Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Res 122 (2003) 193-198
8. Tebartz van Elst L., Hesslinger B., Thiel T., Geiger E., Haegele K., Lemieux L., et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: A volumetric magnetic resonance imaging study. Biol Psychiatry 54 (2003) 163-171
9. Soloff P., Nutche J., Goradia D., and Diwadkar V. Structural brain abnormalities in borderline personality disorder: A voxel-based morphometry study. Psychiatry Res 164 (2008) 223-236
10. Brambilla P., Soloff P.H., Sala M., Nicoletti M.A., Keshavan M.S., and Soares J.C. Anatomical MRI study of borderline personality disorder patients. Psychiatry Res 131 (2004) 125-133
11. Zetzsche T., Frodl T., Preuss U.W., Schmitt G., Seifert D., Leinsinger G., et al. Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol Psychiatry 60 (2006) 302-310
12. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Mitelman S.A., Newmark R., et al. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 32 (2007) 1629-1640
13. Minzenberg M.J., Fan J., New A.S., Tang C.Y., and Siever L.J. Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res 42 (2008) 727-733
14. Herpertz S.C., Dietrich T.M., Wenning B., Krings T., Erberich S.G., Willmes K., et al. Evidence of abnormal amygdala functioning in borderline personality disorder: A functional MRI study. Biol Psychiatry 50 (2001) 292-298
15. Donegan N.H., Sanislow C.A., Blumberg H.P., Fulbright R.K., Lacadie C., Skudlarski P., et al. Amygdala hyperreactivity in borderline personality disorder: Implications for emotional dysregulation. Biol Psychiatry 54 (2003) 1284-1293
16. Beblo T., Driessen M., Mertens M., Wingenfeld K., Piefke M., Rullkoetter N., et al. Functional MRI correlates of the recall of unresolved life events in borderline personality disorder. Psychol Med 36 (2006) 845-856
17. Koenigsberg H.W., Siever L.J., Lee H., Pizzarello S., New A.S., Goodman M., et al. Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res 172 (2009) 192-199
18. Minzenberg M.J., Fan J., New A.S., Tang C.Y., and Siever L.J. Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: An event-related fMRI study. Psychiatry Res 155 (2007) 231-243
19. Silbersweig D., Clarkin J.F., Goldstein M., Kernberg O.F., Tuescher O., Levy K.N., et al. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry 164 (2007) 1832-1841
20. Tebartz van Elst L., Ludaescher P., Thiel T., Buchert M., Hesslinger B., Bohus M., et al. Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder. Neurosci Lett 417 (2007) 36-41
21. Wittchen H.U., Wunderlich U., and Zaudig M. Strukturiertes Klinisches Interview für DSM-IV, Achse I: Psychische Störungen (1997), Hogrefe, Göttingen
22. Loranger A.W. International personality disorder examination (IPDE): DSM-IV and ICD-10 modules (1999), Psychological Assessment Resources, Odessa, FL
23. Laux L., Glanzmann P., Schaffner P., and Spielberger C.D. Das State-Trait-Angstinventar. Theoretische Grundlagen und Handanweisung (1981), Beltz, Weinheim
24. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
25. Patton J.H., Stanford M.S., and Barratt E.S. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51 (1995) 768-774
26. Bohus M., Limberger M.F., Frank U., Chapman A.L., Kuhler T., and Stieglitz R.D. Psychometric properties of the borderline symptom list (BSL). Psychopathology 40 (2007) 126-132
27. Freyberger H.J., Spitzer C., and Stieglitz R.D. Fragebogen zu Dissoziativen Symptomen (FDS) (1999), Verlag Hans Hubner, Bern
28. Schubert F., Gallinat J., Seifert F., and Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 21 (2004) 1762-1771
29. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 (1993) 672-679
30. Soher B.J., Young K., Bernstein A., Aygula Z., and Maudsley A.A. GAVA: Spectral simulation for in vivo MRS applications. J Magn Reson 185 (2007) 291-299
31. Christiansen P., Henriksen O., Stubgaard M., Gideon P., and Larsson H.B. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging 11 (1993) 107-118
32. Weber-Fahr W., Ende G., Braus D.F., Bachert P., Soher B.J., Henn F.A., et al. A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia. Neuroimage 16 (2002) 49-60
33. Ethofer T., Mader I., Seeger U., Helms G., Erb M., Grodd W., et al. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med 50 (2003) 1296-1301
34. Traber F., Block W., Lamerichs R., Gieseke J., and Schild H.H. 1H metabolite relaxation times at 3.0 Tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 19 (2004) 537-545
35. Linehan M.M., Bohus M., and Lynch T. Dialectical behavior therapy for pervasive emotion dysregulation: Theoretical and practical underpinnings. In: Gross J.J. (Ed). Handbook of Emotion Regulation (2006), Guilford Press, New York 581-605
36. van Elst L.T., Thiel T., Hesslinger B., Lieb K., Bohus M., Hennig J., et al. Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. J Neuropsychiatr Clin Neurosci 13 (2001) 511-514
37. Rusch N., Boeker M., Buchert M., Glauche V., Bohrmann C., Ebert D., et al. Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. World J Biol Psychiatry (2008) 1-10
38. Amaral D.G., Price J.L., Pirkaenen A., and Carmichael S.T. Anatomical organization of the primate amygdaloid complex. In: Aggleton J.P. (Ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction (1992), Wiley-Liss, New York 1-66
39. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 23 (2000) 155-184
40. Steen R.G., Hamer R.M., and Lieberman J.A. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and meta-analysis. Neuropsychopharmacology 30 (2005) 1949-1962
41. De Stefano N., and Filippi M. MR spectroscopy in multiple sclerosis. J Neuroimaging 17 suppl 1 (2007) 31S-35S
42. Block W., Traber F., Flacke S., Jessen F., Pohl C., and Schild H. In-vivo proton MR-spectroscopy of the human brain: Assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 23 (2002) 317-323
43. Schuff N., Neylan T.C., Lenoci M.A., Du A.T., Weiss D.S., Marmar C.R., et al. Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry 50 (2001) 952-959
44. Brendel G.R., Stern E., and Silbersweig D.A. Defining the neurocircuitry of borderline personality disorder: Functional neuroimaging approaches. Dev Psychopathol 17 (2005) 1197-1206
45. Schmahl C., Berne K., Krause A., Kleindienst N., Valerius G., Vermetten E., et al. Hippocampus and amygdala volumes in patients with borderline personality disorder with or without posttraumatic stress disorder. J Psychiatry Neurosci 34 (2009) 289-295
46. Kraus A., Esposito F., Seifritz E., Di Salle F., Ruf M., Valerius G., et al. Amygdala deactivation as a neural correlate of pain processing in patients with borderline personality disorder and co-occurrent posttraumatic stress disorder. Biol Psychiatry 65 (2009) 819-822
47. Schuff N., Ezekiel F., Gamst A.C., Amend D.L., Capizzano A.A., Maudsley A.A., et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 45 (2001) 899-907
48. Danielsen E.R., and Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases (1999), Marcel Dekker, New York
49. Li B.S., Wang H., and Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 21 (2003) 923-928
50. Lowry O.H., Berger S.J., Chi M.M., Carter J.G., Blackshaw A., and Outlaw W. Diversity of metabolic patterns in human brain tumors-I. High energy phosphate compounds and basic composition. J Neurochem 29 (1977) 959-977
51. Ende G., Braus D.F., Walter S., Weber-Fahr W., and Henn F.A. The hippocampus in patients treated with electroconvulsive therapy: A proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 57 (2000) 937-943
52. Distel M.A., Rebollo-Mesa I., Willemsen G., Derom C.A., Trull T.J., Martin N.G., et al. Familial resemblance of borderline personality disorder features: Genetic or cultural transmission?. PLoS ONE 4 (2009) e5334
53. Ende G., Braus D.F., Walter S., Weber-Fahr W., Soher B., Maudsley A.A., et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 41 (2000) 389-395
54. Szulc A., Galinska B., Tarasow E., Dzienis W., Kubas B., Konarzewska B., et al. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). Pharmacopsychiatry 38 (2005) 214-219